Medical Bulletin 07/ December/ 2024 Yakshi Chugh7 Dec 2024 3:00 PM ISTHere are the top medical news for the day:More behavioral Issues with Use of Antipsychotic Drugs: Study FindsA new study conducted by researchers at...
More behavioral Issues with Use of Antipsychotic Drugs: Study Finds Yakshi Chugh7 Dec 2024 8:00 AM ISTA new study conducted by researchers at the University of Waterloo analyzed data from nearly 500,000 Canadian patients who lived in nursing homes...
IQVIA Gets CDSCO Panel Nod to Study Antipsychotic drug Lumateperone Dr. Divya Colin17 Nov 2024 5:45 PM ISTNew Delhi: IQVIA has got approval from the Subject Expert Committee (SEC) functional under the Central Drug Standard Control Organisation (CDSCO) to...
Torrent Pharma gets CDSCO Panel nod to study Brexpiprazole tablet to treat schizophrenia Dr. Divya Colin26 Nov 2023 5:00 PM ISTNew Delhi: Citing that the clinical trial sites should be geographically distributed in the country, the Subject Expert Committee (SEC) functional...
FDA approved antipsychotic brexpiprazole shows no meaningful benefit, may raise mortality risk: finds study Dr. Kamal Kant Kohli22 Aug 2023 11:45 AM ISTUSA: The US Food and Drug Administration (FDA) has fast-tracked the approval of the antipsychotic drug brexpiprazole (Rexulti) despite its failure to...
Revise CT protocol: CDSCO Panel tells Intas on antipsychotic Drug Endoxifen Dr. Divya Colin27 March 2023 6:00 PM ISTNew Delhi: Noting that the study drug Endoxifen is already approved in India since 10-12-2019 for proposed indication, the Subject Expert Committtee...
Sun Pharma's proposal to amend CT protocol for pimavanserin gets CDSCO Panel nod Dr. Divya Colin2 Jan 2023 6:00 PM ISTNew Delhi: Approving Sun Pharma's proposal to amend the existing clinical trial protocol for the atypical antipsychotic Pimavanserin Capsules, the...
Johnson and Johnson gets CDSCO panel nod to study Paliperidone Palmitate Roshni Dhar1 Oct 2022 5:53 PM ISTPharmaceutical major, Johnson and Johnson has got a go ahead from the Subject Expert Committee SEC functional under Central Drug Standard Control...
Health Bulletin 30/September/2022 Roshni Dhar30 Sept 2022 5:34 PM ISTHere are the top health news for the day:Delhi: Safdarjung Hospital to ban 3-wheelerIn an order to curb pollution, Safdarjung Hospital is going to ban...
Use of second-generation antipsychotic drugs tied to reduced risk of Covid-19 infection: JAMA Medical Dialogues Editorial Team9 May 2022 9:00 AM ISTThe usage of second-generation antipsychotic medicines was related with a lower incidence of COVID-19 infection in people hospitalized with...
Sun Pharma gets CDSCO panel okay for phase 3 trial of Pimavanserin Dr. Divya Colin29 Jan 2022 12:51 PM ISTNew Delhi: Pharmaceutical major, Sun Pharma has got a go-ahead from the Subject Expert Committee (SEC) functional under the Central Drug Standard...
